Cover Image

The fungal meningitis outbreak : could it have been prevented? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, November 14, 2012.

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (Author)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. Government Printing Office, 2014.
Subjects:	Meningitis > United States > Prevention. Drugs > Dosage forms > Health aspects > United States. Drug factories > Inspection > United States. Pharmaceutical industry > Government policy > United States. Legislative hearings.
Online Access:	https://purl.fdlp.gov/GPO/gpo51505 http://purl.fdlp.gov/GPO/gpo51505

Similar Items

A continuing investigation into the fungal meningitis outbreak and whether it could have been prevented : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, April 16, 2013.
Published: (2015)

Pharmacy compounding: implications of the 2012 meningitis outbreak : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, second session ... November 15, 2012.
Published: (2015)

A Continuing Investigation into the Fungal Meningitis Outbreak and Whether It Could Have Been Prevented.
Published: (2013)

Examining drug compounding : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, May 23, 2013.
Published: (2014)

The Fungal Meningitis Outbreak : Could It Have Been Prevented?
Published: (2012)

Pharmacy Compounding : Implications of the 2012 Meningitis Outbreak.
Published: (2012)

Reforming the drug compounding regulatory framework : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, July 16, 2013.
Published: (2014)

60 minutes.
Published: (2013)

Meningitis : a medical dictionary, bibliography, and annotated research guide to Internet references /
Published: (2003)

Ansel's pharmaceutical dosage forms and drug delivery systems /
by: Allen, Loyd V., Jr, et al.
Published: (2023)

Tuberculous meningitis : manual of diagnosis and therapy /
Published: (2020)

Drug delivery : principles and applications /
Published: (2016)

Memorandum report : high-risk compounded sterile preparations and outsourcing by hospitals that use them.
Published: (2013)

A practical guide to contemporary pharmacy practice and compounding /
by: Elder, Deborah Lester
Published: (2018)

Bacterial meningitis /
by: Tunkel, Allan R.
Published: (2001)

Curbing the tide of meningitis /
Published: (2010)

Galenics of insulin : the physico-chemical and pharmaceutical aspects of insulin and insulin preparations /
by: Brange, Jens, 1940-
Published: (1987)

Drug compounding for animals : FDA could improve oversight with better information and guidance : report to congressional committees.
Published: (2015)

Solid state properties of pharmaceutical materials /
by: Byrn, Stephen R., et al.
Published: (2017)

Meningitis : cellular and molecular basis /
Published: (2013)

Meningitis y encefalitis.

Pharmaceutical suspensions : from formulation development to manufacturing /
Published: (2010)

Oral formulation roadmap from early drug discovery to development /
Published: (2017)

Federal and state role in pharmacy compounding and reconstitution : exploring the right mix to protect patients : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, first session, on examining state and federal oversight to ensure the safety and quality of drug compounding--the process of mixing, combining, or altering ingredients to create a customized medication for an individual patient--by pharmacies, October 23, 2003.
Published: (2004)

Federal and state role in pharmacy compounding and reconstitution : exploring the right mix to protect patients : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, first session, on examining state and federal oversight to ensure the safety and quality of drug compounding--the process of mixing, combining, or altering ingredients to create a customized medication for an individual patient--by pharmacies, October 23, 2003.
Published: (2004)

Specialized drug delivery systems : manufacturing and production technology /
Published: (1990)

Integrated pharmaceutics : applied preformulation, product design, and regulatory science.
by: AL-ACHI, ANTOINE
Published: (2022)

AAPS PharmSciTech.
Published: (2000)

Dosage forms, formulation developments, and regulations : recent and future trends in pharmaceutics.
Published: (2024)

Meningitis and encephalitis fact sheet.

Guidance for industry : SUPAC-SS : nonsterile semisolid dosage forms : manufacturing equipment addendum.
Published: (1998)

Solid state characterization of pharmaceuticals /
Published: (2011)

Formulating pharma-, nutra-, and cosmeceutical products from herbal substances : dosage forms and delivery systems /
Published: (2025)

Recent advances in drug delivery systems /
Published: (1984)

Solid state development and processing of pharmaceutical molecules : salts, cocrystals, and polymorphism /
by: Gruss, Michael
Published: (2022)

Pharmaceutical process scale-up /
Published: (2006)

Design and manufacture of pharmaceutical tablets /
by: Eyjolfsson, Reynir
Published: (2015)

Guidance for industry : extended release oral dosage forms, development, evaluation, and application of in vitro/in vivo correlations.
Published: (1997)

Pharmaceutics : basic principles and application to pharmacy practice.
Published: (2024)

Drug and enzyme targeting.
Published: (1985)